• 1
    Bush, P.A., Aronson, W.J., Buga, G.M., Rajfer, J., Ignarro, L.J. (1992) Nitric oxide is a potent relaxant of human and rabbit corpus cavernosum. J. Urol. 147, 16501655.
  • 2
    Burnett, A.L., Lowenstein, C.J., Bradt, D.S., Chang, T.S.K., Snyder, S.H. (1992) Nitric oxide in the penis: physiology and pathology. Science 257, 401403.
  • 3
    Wagner, G. & de Tejada, S. (1998) Update on male erectile dysfunction. Br. Med. J. 316, 678682.
  • 4
    Corbin, J.D. & Francis, S.H. (1999) Cyclic GMP phosphodiesterase 5: target for sildenafil. J. Biol. Chem. 274, 1372913732.
  • 5
    Boolell, M., Allen, M.J., Ballard, S.A., Gepi-Attee, S., Muirhead, G.J., Naylor, A.M., Osterloh, I.H., Gingell, C. (1996) Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int. J. Impotence Res. 8, 4752.
  • 6
    Corbin, J.D., Turko, I.V., Beasley, A., Francis, S.H. (2000) Phosphorylation of phosphodiesterase-5 by cyclic nucleotide-dependent protein kinase alters its catalytic and allosteric cGMP-binding activities. Eur. J. Biochem. 267, 27602767.DOI: 10.1046/j.1432-1327.2000.01297.x
  • 7
    Loten, E.G. & Sneyd, J.G. (1973) Evidence for separate sites of action for the antilipolytic effects of insulin and prostaglandin E1. Endocrinology 93, 13151322.
  • 8
    Degerman, E., Belfrage, P., Manganiello, V.C. (1997) Structure, localization, and regulation of cGMP-inhibited phosphodiesterase (PDE3). J. Biol. Chem. 272, 68236826.
  • 9
    Corbin, J.D., Beebe, S.J., Blackmore, P.F. (1985) cAMP-dependent protein kinase activation lowers hepatocyte cAMP. J. Biol. Chem. 260, 87318735.
  • 10
    Sette, C., Iona, S., Conti, M. (1994) The short-term activation of a Rolipram-sensitive, cAMP-specific phosphodiesterase by thyroid-stimulating hormone in thyroid FRTL-5 cells is mediated by a cAMP-dependent phosphorylation. J. Biol. Chem. 269, 92459252.
  • 11
    Conti, M., Iona, S., Cuomo, M., Swinnen, J.V., Odeh, J., Svoboda, M.E. (1995) Characterization of a hormone-inducible, high affinity adenosine 3′-5′-cyclic monophosphate phosphodiesterase from the rat Sertoli cell. Biochemistry 34, 79797987.
  • 12
    Swinnen, J.V., Joseph, D.R., Conti, M. (1989) The mRNA encoding a high-affinity cAMP phosphodiesterase is regulated by hormones and cAMP. Proc. Natl Acad. Sci. USA 86, 81978201.
  • 13
    Shabb, J.B. & Corbin, J.D. (1992) Cyclic nucleotide-binding domains in proteins having diverse functions. J. Biol. Chem. 267, 57235726.
  • 14
    Jiang, H., Colbran, J.L., Francis, S.H., Corbin, J.D. (1992) Direct evidence for cross-activation of cGMP-dependent protein kinase by cAMP in pig coronary arteries. J. Biol. Chem. 267, 10151019.
  • 15
    Francis, S.H., Noblett, B.D., Todd, B.W., Wells, J.N., Corbin, J.D. (1988) Relaxation of vascular and tracheal smooth muscle by cyclic nucleotide analogs that preferentially activate purified cGMP-dependent protein kinase. Mol. Pharmacol. 34, 506517.
  • 16
    Gillespie, P.G. (1990) Phosphodiesterases in visual transduction by rods and cones. In Cyclic Nucleotide Phosphodiesterases: Structure, Regulation and Drug Action (Beavo, J. & Houslay, M.D., eds), pp. 163184. John Wiley and Sons, Chichester, UK.
  • 17
    Francis, S.H., Wolfe L., Corbin, J.D. (1991) Purification of type I alpha and type I beta isozymes and proteolyzed type I beta monomeric enzyme of cGMP-dependent protein kinase from bovine aorta. Methods Enzymol. 200, 332341.
  • 18
    Glass, D.B. & Krebs, E.G. (1982) Phosphorylation by guanosine 3′:5′-monophosphate-dependent protein kinase of synthetic peptide analogs of a site phosphorylated in histone H2B. J. Biol. Chem. 257, 11961200.
  • 19
    Cheng, H.C., Kemp, B.E., Pearson, R.B., Smith, A.J., Van Misconi, L., Patten, S.M., Walsh, D.A. (1986) A potent synthetic peptide inhibitor of the cAMP-dependent protein kinase. J. Biol. Chem. 261, 989992.
  • 20
    Martins, T.J., Mumby, M.C., Beavo, J.A. (1982) Purification and characterization of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase from bovine tissues. J. Biol. Chem. 257, 19731979.
  • 21
    Wolfe, L., Corbin, J.D., Francis, S.H. (1989) Characterization of a novel isozyme of cGMP-dependent protein kinase from bovine aorta. J. Biol. Chem. 264, 77347741.
  • 22
    Thomas, M.K., Francis, S.H., Corbin, J.D. (1990) Characterization of a purified bovine lung cGMP-binding cGMP phosphodiesterase. J. Biol. Chem. 265, 1496414970.
  • 23
    Qiu, Y., Kraft, P., Lombardi, E., Clancy, J. (2000) Rabbit corpus cavernosum smooth muscle shows a different phosphodiesterase profile than human corpus cavernosum. J. Urology 164, 882886.
  • 24
    Sonnenburg, W.K., Seger, D., Kwak, K.S., Huang, J., Charbonneau, H., Beavo, J.A. (1995) Identification of inhibitory and calmodulin-binding domains of the PDE1A1 and PDE1A2 calmodulin-stimulated cyclic nucleotide phosphodiesterases. J. Biol. Chem. 270, 3098931000.
  • 25
    Wolfe, L., Francis, S.H., Corbin, J.D. (1989) Properties of a cGMP-dependent monomeric protein kinase from bovine aorta. J. Biol. Chem. 264, 41574162.
  • 26
    Corbin, J.D., Gettys, T.W., Blackmore, P.F., Beebe, S.J., Francis, S.H., Glass, D.B., Redmon, J.B., Sheorain, V.S., Landiss, L.R. (1988) Purification and assay of cAMP, cGMP, and cyclic nucleotide analogs in cells treated with cyclic nucleotide analogs. Methods Enzymol. 159, 7482.
  • 27
    Bush, P.A., Aronson, W.J., Rajfer, J., Ignarro, L.J. (1993) The l-arginine-nitric oxide-cyclic GMP pathway mediates inhibitory nonadrenergic-noncholinergic neurotransmission in the corpus cavernosum of human and rabbit. Circulation 87, V30V32.
  • 28
    Francis, S.H., Lincoln, T.M., Corbin, J.D. (1980) Characterization of a novel cGMP binding protein from rat lung. J. Biol. Chem. 255, 620626.
  • 29
    Turko, I.V., Francis, S.H., Corbin, J.D. (1999) Studies of the molecular mechanism of discrimination between cGMP and cAMP in the allosteric cyclic nucleotide-binding sites of the cGMP-binding cGMP-specific phosphodiesterase. J. Biol. Chem. 274, 2903829041.
  • 30
    Eigenthaler, M., Nolte, C., Halbrugge, M., Walter, U. (1992) Concentration and regulation of cyclic nucleotides, cyclic- nucleotide-dependent protein kinases and one of their major substrates in human platelets. Estimating the rate of cAMP-regulated and cGMP-regulated protein phosphorylation in intact cells. Eur. J. Biochem. 205, 471481.
  • 31
    Keely, S.L. & Corbin, J.D. (1977) Involvement of cAMP-dependent protein kinase in the regulation of heart contractile force. Am. J. Physiol. 233, H269H275.
  • 32
    Biel, M., Altenhofen, W., Hullin, R., Ludwig, J., Freichel, M., Flockerzi, V., Dascal, N., Kaupp, U.B., Hofmann, F. (1993) Primary structure and functional expression of a cyclic nucleotide-gated channel from rabbit aorta. FEBS Lett. 329, 134138.
  • 33
    Yao, X.Q., Segal, A.S., Welling, P., Zhang, X.Q., McNicholas, C.M., Engel, D., Boulpaep, E.L., Desir, G.V. (1995) Primary structure and functional expression of a cGMP-gated potassium channel. Proc. Natl Acad. Sci. USA 92, 1171111715.
  • 34
    Weber, G. (1975) Energetics of ligand binding to protein. Adv. Protein Chem. 29, 183.
  • 35
    Sette, C. & Conti, M. (1996) Phosphorylation and activation of a cAMP-specific phosphodiesterase by the cAMP-dependent protein kinase. Involvement of serine 54 in the enzyme activation. J. Biol. Chem. 271, 1652616534.
  • 36
    Ballard, S.A., Gingell, C.J., Tang, K., Turner, L.A., Price, M.E., Naylor, A.M. (1998) Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. J. Urol. 159, 21642171.
  • 37
    Jeremy, J.Y., Ballard, S.A., Naylor, A.M., Miller, M.A., Angelini, G.D. (1997) Effects of sildenafil, a type-5 cGMP phosphodiesterase inhibitor, and papaverine on cyclic GMP and cyclic AMP levels in the rabbit corpus cavernosum in vitro. Br. J. Urol. 79, 958963.
  • 38
    Zusman, R.M., Morales, A., Glasser, D.B., Osterloh, I.H. (1999) Overall cardiovascular profile of sildenafil citrate. Am. J. Cardiol. 83, 35C44C.